PNPLA3 and steatosis: After the demonstration that PNPLA3 p.I148M protein accumulates on LDs due to resistance to ubiquitylation [50] and that this is necessary for the phenotypic expression of steatosis, we hypothesised that targeting mutant PNPLA3 for silencing may represent a therapeutic approach in carriers [51].